SyntheticMR Balance Sheet Health
Financial Health criteria checks 6/6
SyntheticMR has a total shareholder equity of SEK116.6M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK143.0M and SEK26.4M respectively. SyntheticMR's EBIT is SEK14.1M making its interest coverage ratio -115.4. It has cash and short-term investments of SEK21.3M.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | -115.4x |
| Cash | SEK 21.32m |
| Equity | SEK 116.57m |
| Total liabilities | SEK 26.39m |
| Total assets | SEK 142.97m |
Recent financial health updates
No updates
Recent updates
Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?
Dec 20
What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?
Sep 21Some Investors May Be Worried About SyntheticMR's (NGM:SYNT) Returns On Capital
Mar 18There Are Reasons To Feel Uneasy About SyntheticMR's (NGM:SYNT) Returns On Capital
Nov 29What Does SyntheticMR AB (publ)'s (NGM:SYNT) Share Price Indicate?
Aug 06Why SyntheticMR AB (publ) (NGM:SYNT) Could Be Worth Watching
Feb 23A Look At The Intrinsic Value Of SyntheticMR AB (publ) (NGM:SYNT)
Jan 27Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?
Nov 10Read This Before Selling SyntheticMR AB (publ) (NGM:SYNT) Shares
Mar 09What Percentage Of SyntheticMR AB (publ) (NGM:SYNT) Shares Do Insiders Own?
Feb 11
SyntheticMR AB (publ) (NGM:SYNT) Insiders Increased Their Holdings
Dec 03Financial Position Analysis
Short Term Liabilities: SYNT's short term assets (SEK118.4M) exceed its short term liabilities (SEK26.2M).
Long Term Liabilities: SYNT's short term assets (SEK118.4M) exceed its long term liabilities (SEK235.0K).
Debt to Equity History and Analysis
Debt Level: SYNT is debt free.
Reducing Debt: SYNT had no debt 5 years ago.
Debt Coverage: SYNT has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: SYNT has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/04/29 03:48 |
| End of Day Share Price | 2024/01/31 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SyntheticMR AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Simon Larsson | Danske Bank |
| Christian Lee | Pareto Securities |